RAAS Inhibitor Drugs in Dialysis Patients

NCT01635387 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
End Stage Renal Disease

Interventions

DRUG: aliskiren

Sponsor

University of Campania Luigi Vanvitelli

Collaborators

[object Object]